Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

The Ohio State University, Dana-Farber Cancer Institute, The University of Texas MD Anderson Cancer Center, Hofstra University, Mayo Clinic in Arizona, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Cancer Institute (WIA), Stanford University, Stanford Cancer Institute, St Vincent's Hospital, Peter MacCallum Cancer Centre, St. Vincent's Hospital, Royal North Shore Hospital, Medical University of Vienna, University of Rochester, New York Hospital Queens, NewYork–Presbyterian Hospital, Presbyterian Hospital, Cornell University, Moores Cancer Center, Hôpital Avicenne, Pharmacyclics (United States), East Kent Hospitals University NHS Foundation Trust, Beaumont Hospital, Copernicus Memorial Hospital, Medical University of Lodz, Hospital Clínic de Barcelona, University of Pennsylvania, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Oxford Biomedical Research, University of California, Los Angeles, Princess Alexandra Hospital, The Christie NHS Foundation Trust, Royal Marsden Hospital, Hospital de Sant Pau